Results 231 to 240 of about 106,748 (296)

Transport of cytotoxic cyanine dyes coupled to siRNA into hematopoietic cancer cells with CD20-, CD22- or CD33-targeting ELART nanocarriers. [PDF]

Sci Rep
Krassuski T, Bäumer N, Niland S, Grunert K, Wittmann L, Eble JA, Lenz G, Berdel WE, Bäumer S.   +8 more
europepmc   +1 more source

Investigation of IgM Monoclonal Paraprotein in Bone Marrow Aspiration: The Role of Immunophenotyping by Flow Cytometry in Selecting Cases for Molecular Testing for the p.MYD88 L265P Point Mutation

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Background Flow cytometry and real‐time quantitative polymerase chain reaction (qRT‐PCR) for MYD88 mutations (MYD88mt) are routinely performed on bone marrow aspirates during the diagnostic evaluation of IgM monoclonal paraproteinemia. The potential predictive value of immunophenotypic findings for molecular results, however, remains to be ...
Georgios Boutsikas, Konstantinos Agiannitopoulos, Elisavet Kouvidi, Myrto Katraki, Athanasios Papatheodorou, Anna Roussou, Nikolaos Paschalidis, Theodoros P. Vassilakopoulos, Ioannis Anagnostopoulos, Dimitra Sasaroli, Aglaia Dimitrakopoulou   +10 more
wiley   +1 more source

Development of tandem canine CAR T cells to enable comparative studies of aggressive B-cell lymphoma. [PDF]

Mol Cancer Ther
Peng B, Jiang L, Lenz JA, Cesar Conti L, Rotolo A, Mason NJ, Atherton MJ.   +6 more
europepmc   +1 more source

Primary cutaneous acral CD8‐positive lymphoproliferative disorder of the auricles: An unusual long‐term course

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Anna Sophia Flechtenmacher, Cyrill Géraud, Jan Peter Nicolay   +2 more
wiley   +1 more source

Targeted therapies in pemphigus vulgaris: Emerging horizons beyond rituximab

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Rituximab‐refractory pemphigus vulgaris is driven by B‐cell repopulation, plasma‐cell persistence, IgG4 autoantibodies and anti‐drug antibodies. This review evaluates five emerging targeted classes acting at successive steps of disease: next‐generation anti‐CD20 antibodies, DSG3‐CAAR T cells, BTK inhibitors, BAFF/APRIL inhibitors and FcRn antagonists ...
Rhea Ahuja, Dedee Murrell
wiley   +1 more source

Complement-Dominant Relapse of Mixed Autoimmune Hemolytic Anemia After Rituximab Response. [PDF]

EJHaem
Tomigaki N, Kakiuchi S, Sakamoto A, Fujioka S, Harima I, Akiyama H, Niwa R, Takagi I, Kozuki Y, Miyata Y, Tanaka S, Tsuji H, Iwata N.   +12 more
europepmc   +1 more source

Placental malperfusion and angiogenesis‐related proteins are associated with small‐for‐gestational‐age in systemic lupus erythematosus

Journal of Internal Medicine, EarlyView.
Abstract Background Although systemic lupus erythematosus (SLE) pregnancy frequently results in small for gestational age (SGA) infants, the understanding of underlying mechanisms is limited. We aimed to identify specific histological patterns of placental injury in SGA in SLE and to explore whether an altered balance of angiogenesis‐related proteins ...
Marit Stockfelt, Henri Puttonen, Ing‐Marie Fyhr, Agnes Torell, Kerstin Andersson, Iva Gunnarsson, Elisabet Svenungsson, Agneta Zickert, Maria Majczuk Sennström, Estelle Trysberg, Anders A. Bengtsson, Andreas Jönsen, Helena Strevens, Christopher Sjöwall, Muna Saleh, Sofia Pihl, Dag Leonard, Lars Rönnblom, Tansim Akhter, Bo Jacobsson, Anna‐Carin Lundell, Anna Rudin   +21 more
wiley   +1 more source

CD20 as a target for therapy

Central European Journal of Immunology, 2007
Magdalena Winiarska, Bil, Jacek, Urszula Anna Demkow, Wąsik, Maria   +3 more
openaire   +1 more source

Personalised Anti-CD20 Retreatment in Multiple Sclerosis: Precision Medicine or Precision Pharmacology? [PDF]

Eur J Neurol
Schmierer K.
europepmc   +1 more source